Acute coronary syndrome secondary to fluorouracil infusion.
Lu
Jack I
JI
State University of New York Upstate Medical University, Syracuse, NY, USA.
Carhart
Robert L
RL
Graziano
Stephen L
SL
Gajra
Ajeet
A
D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000556:secondary*; D002945:Cisplatin / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects*; D006258:Head and Neck Neoplasms / Q000473:pathology / Q000628:therapy; D006801:Humans; D007262:Infusions, Intravenous; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D009203:Myocardial Infarction / Q000139:chemically induced* / Q000175:diagnosis
D000964:Antimetabolites, Antineoplastic; D002945:Cisplatin; D005472:Fluorouracil